VICTORIA MWAREY: Open Payments
NPI 1073286746 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 7 payments from 6 companies in 2025. Trend: 2023 $483 · 2024 $895 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $137 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Averitas Pharma Inc. | 1 | $113 |
| Paratek Pharmaceuticals, Inc. | 1 | $113 |
| Otsuka America Pharmaceutical, Inc. | 1 | $107 |
Products named: AUSTEDO XR, Auvelity, QUTENZA, NUZYRA, Ozempic, REXULTI.
Industry payments across MO — which companies pay providers there.
